help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuhajda, F. P.
Right arrow Articles by Eggleston, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhajda, F. P.
Right arrow Articles by Eggleston, J. C.

American Journal of Pathology, Vol 121, 342-348, Copyright © 1985 by American Society for Investigative Pathology

REGULAR ARTICLES

Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status

FP Kuhajda and JC Eggleston

Pregnancy-associated plasma protein-A (PAPP-A) immunopositivity and extensive tumor necrosis have been shown to correlate significantly with early (less than 24 months) recurrence in patients with Stage I breast carcinoma negative for estrogen receptor (ER). In this study we have extended our analysis of Stage I disease to include 30 ER-positive cases. Twenty-five traditional clinical and pathologic features were reviewed in addition to the immunoperoxidase staining characteristics of PAPP-A for examination of the independent relationship of immunopositivity both to early recurrence and to ER and progesterone receptor (PR) status. Clinical recurrence developed in 6 of 30 (20%) patients, 4 of the 30 (13%) patients experiencing early recurrence. Pearson chi-square tests revealed significant correlations between early recurrence and PAPP-A tumor positivity (P less than 0.002), younger age (P less than 0.009), and premenopausal status (P less than 0.03). Stepwise regression analysis showed that PAPP-A-positive staining correlated independently with early recurrence. Of the 10 PAPP- A-positive tumors, 4 (40%) recurred within 2 years, compared with no early recurrences in the 20 PAPP-A-negative cases. With a comparison of frequency of PAPP-A positivity of ER-positive (30%) tumors and ER- negative tumors (40%), there was no correlation with ER or PR status. PAPP-A tumor positivity is independent of ER status and is a clinically significant independent predictor of early recurrence in both ER- positive and ER-negative Stage I patients.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Society for Investigative Pathology.